Diagnostics & Research · Healthcare
CEO, Board Member, COO
2020-05-01–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Agilent Technologies, Inc. publishes a filing, an earnings call transcript or a press release.
Get A alertsPadraig McDonnell is recorded as Board Member at Agilent Technologies, Inc. (A) since May 1, 2024, COO at Agilent Technologies, Inc. (A) since February 20, 2024 and CEO at Agilent Technologies, Inc. (A). Agilent Technologies, Inc. reported in an 8-K filed May 1, 2024 that Padraig McDonnell was appointed member of the Company's Board, effective May 1, 2024. Agilent Technologies, Inc. reported in an 8-K filed May 1, 2024 that Padraig McDonnell was appointed CEO, effective May 1, 2024. Agilent Technologies, Inc. reported in an 8-K filed February 21, 2024 that Padraig McDonnell was appointed Chief Operating Officer (“COO”) and CEO-elect, effective February 20, 2024. Padraig McDonnell has spoken on 9 earnings calls and 1 other investor event across 1 company, most recently for Agilent Technologies, Inc. on September 23, 2026. Agilent Technologies, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Agilent Technologies, Inc. includes Adam S. Elinoff (CFO), Rodney Gonsalves (CFO), Michael Buckner (General Counsel) and 7 others.
“The Board appointed Padraig McDonnell as CEO of the Company and as a member of the Company's Board.”
“The Board appointed Padraig McDonnell as CEO of the Company and as a member of the Company's Board.”
“So as you see markets steadily improving, what we've been doing over the last two years is really compounding our capability with Ignite, which has moved from a kind of transformation to an overall operating system change.”
“It was a solid start to the year with the Agilent team executing well in a generally improving, albeit dynamic, market environment. For the first quarter, Agilent reported $1.8 billion in revenue, growing 4.4% on a core basis within our November guidance range.”
“Before I talk about our results, I want to start by introducing Adam Elanos, our new CFO who officially joined Agilent last week. Adam joins us after distinguished tenure at Amgen.”
“Agilent delivered outstanding results of $1.74 billion in revenue in the third quarter, exceeding our guidance while continuing to transform our enterprise operating model in a highly dynamic environment.”
“As you saw in our press release, we had a very solid start to the year, exceeding our expectations for core revenue growth and EPS.”
2024-05-01–present
2024-02-20–present
SEC 8-K
2020-05-01–present
Diagnostics & Research · Healthcare
CEO, Board Member, COO
2020-05-01–present